Valisure recently participated in a webinar hosted by the Hypertrophic Cardiomyopathy Association (HCMA) titled Generic Drug Quality Issues: How Do You Know What’s In Your Generic Drugs? The June 26 event brought together experts and advocates to discuss the rising concerns around generic drug safety, transparency, and regulatory oversight.

Panelists included:

• Lisa Salberg, CEO and Founder of HCMA
• David Light, Co-Founder and President of Valisure
• Vic Suarez, Founder of Blu Zone Bioscience & Supply Chain Solutions
• Dr. Harry Lever, Former Medical Director, Cleveland Clinic HCM Center
• Christine Jones, Patient Advocate

Key topics discussed:

• Contamination and inconsistency in the generic drug supply
• Regulatory gaps that impact patient safety
• The patient perspective on medication challenges
• What consumers can do to demand higher standards and transparency

Valisure was proud to contribute to this important conversation as part of our ongoing mission to bring independent quality assurance and accountability to the pharmaceutical supply chain.

Missed the webinar? Stay tuned to HCMA’s site.

‍

Valisure recently participated in a webinar hosted by the Hypertrophic Cardiomyopathy Association (HCMA) titled Generic Drug Quality Issues: How Do You Know What’s In Your Generic Drugs? The June 26 event brought together experts and advocates to discuss the rising concerns around generic drug safety, transparency, and regulatory oversight.

Panelists included:

• Lisa Salberg, CEO and Founder of HCMA
• David Light, Co-Founder and President of Valisure
• Vic Suarez, Founder of Blu Zone Bioscience & Supply Chain Solutions
• Dr. Harry Lever, Former Medical Director, Cleveland Clinic HCM Center
• Christine Jones, Patient Advocate

Key topics discussed:

• Contamination and inconsistency in the generic drug supply
• Regulatory gaps that impact patient safety
• The patient perspective on medication challenges
• What consumers can do to demand higher standards and transparency

Valisure was proud to contribute to this important conversation as part of our ongoing mission to bring independent quality assurance and accountability to the pharmaceutical supply chain.

Missed the webinar? Stay tuned to HCMA’s site.

‍